Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Efrain Santiago PharmD, MBA Disclaimer This information is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment
Tirzepatide is a dual-action medication that targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), making it slightly more effective for weight loss than semaglutide
Over the past decade or so, numerous studies have shown positive effects, on IR, of several insulin sensitizers such as metformin (5), as well as of several complementary substances such as myo-inositol (6, 19), d-chiro inositol (7), alpha lipoic acid (24), or combinations of these (9, 10)
Monitor your response and maintain regular follow-up with your healthcare team
Seek medical advice if fatigue: Persists beyond several months without improvement, despite adequate nutrition and hydration Worsens progressively or becomes debilitating, significantly impairing daily activities or work capacity Is accompanied by severe or persistent gastrointestinal symptoms (intractable nausea, vomiting, diarrhoea, abdominal pain) Occurs alongside signs of dehydration (dark urine, dizziness, reduced urine output, dry mouth) Is associated with symptoms of hypoglycaemia (tremor, sweating, confusion, palpitations), particularly in patients taking concurrent insulin or sulphonylureas Urgent medical attention is required if patients experience: Severe abdominal pain , especially if radiating to the back, which may indicate pancreatitisa rare but serious adverse effect of GLP-1 medications
%20(1).png)
US$ 26.59
US$ 23.16
US$ 23.52
US$ 24.41
